Elzonris Euroopa Liit - eesti - EMA (European Medicines Agency)

elzonris

stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastilised ained - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).

Nexpovio Euroopa Liit - eesti - EMA (European Medicines Agency)

nexpovio

stemline therapeutics b.v. - selinexor - mitu müeloomit - antineoplastilised ained - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.

Orserdu Euroopa Liit - eesti - EMA (European Medicines Agency)

orserdu

stemline therapeutics b.v. - elacestrant - rinnanäärmed - endokriinset ravi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

TachoSil Euroopa Liit - eesti - EMA (European Medicines Agency)

tachosil

corza medical gmbh - inimese fibrinogeen, inimese trombiin - hemostaas, kirurgiline - antihemorraagilised ained - tachosil is indicated in adults and children from 1 month of age for supportive treatment in surgery for improvement of haemostasis, to promote tissue sealing and for suture support in vascular surgery where standard techniques are insufficient. tachosil is indicated in adults for supportive sealing of the dura mater to prevent postoperative cerebrospinal leakage following neurological surgery (see section 5.

FULVESTRANT ACCORD süstelahus süstlis Eesti - eesti - Ravimiamet

fulvestrant accord süstelahus süstlis

accord healthcare b.v. - fulvestrant - süstelahus süstlis - 250mg 5ml 5ml 2tk